Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Qinglei Gao and Ruidi Yu.
Qinglei Gao
Connection Strength
1.815
Ruidi Yu
  1. Development and validation of an online model to predict critical COVID-19 with immune-inflammatory parameters. J Intensive Care. 2021 Feb 18; 9(1):19.
    View in: PubMed
    Score: 0.233
  2. Immunological alternation in COVID-19 patients with cancer and its implications on mortality. Oncoimmunology. 2021 01 04; 10(1):1854424.
    View in: PubMed
    Score: 0.231
  3. A real-world study of glucocorticoid treatment in COVID-19 patients with different disease severities. Clin Transl Med. 2020 Dec; 10(8):e235.
    View in: PubMed
    Score: 0.229
  4. CIRPMC: An online model with simplified inflammatory signature to predict the occurrence of critical illness in patients with COVID-19. Clin Transl Med. 2020 Oct; 10(6):e210.
    View in: PubMed
    Score: 0.226
  5. Immunity-modulated sex disparity on COVID-19 prognosis. Clin Transl Med. 2020 Sep; 10(5):e164.
    View in: PubMed
    Score: 0.225
  6. In-hospital use of ACEI/ARB is associated with lower risk of mortality and critic illness in COVID-19 patients with hypertension. J Infect. 2020 11; 81(5):816-846.
    View in: PubMed
    Score: 0.224
  7. Risk factors for developing into critical COVID-19 patients in Wuhan, China: A multicenter, retrospective, cohort study. EClinicalMedicine. 2020 Aug; 25:100471.
    View in: PubMed
    Score: 0.224
  8. Alteration of serum markers in COVID-19 and implications on mortality. Clin Transl Med. 2020 Jul; 10(3):e119.
    View in: PubMed
    Score: 0.223
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.